StockData
Oruka Therapeutics, Inc. logo

Oruka Therapeutics, Inc. (ORKA) stock

ORKANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$95.74−0.58 (-0.60%)

Close on Nov 18, 2026Market cap $6.34BP/E –Yield –

Oruka Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Oruka Therapeutics's market cap was $6.54B on Nov 11, 2026, against $1.46B a year earlier. Over the last 5 years it ranged from $274.96M to $6.54B, with a median of $410.35M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$6.54B+346.3%
2025Dec 31, 2025$1.47B+116.1%
2024Dec 31, 2024$678.62M+130.8%
2023Dec 29, 2023$293.98M-28.3%
2022Dec 30, 2022$409.84M+10.2%
2021Dec 31, 2021$371.80M-16.8%
2020Dec 31, 2020$446.84M+309.0%
2019Dec 31, 2019$109.24M+98.1%
2018Dec 31, 2018$55.14M-71.0%
2017Dec 29, 2017$190.35M-38.7%
2016Dec 30, 2016$310.55M-38.5%
2015Dec 31, 2015$504.98M+109.5%
2014Dec 31, 2014$241.00M-9.4%
2013Dec 31, 2013$266.02M+378.8%
2012Dec 31, 2012$55.55M-56.0%
2011Dec 30, 2011$126.19M–

More Oruka Therapeutics figures

See a number that looks wrong?